← Back to Search

Startle Adjuvant Rehabilitation Therapy for Stroke

Phase < 1
Recruiting
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in emg onset from baseline (before training on day 1) to post (after training on day 3)
Awards & highlights

Study Summary

This trial will study how a therapy (START) can improve arm function after stroke. Patients will get 3 days of arm training, with or without START, & be assessed at 3 time points for changes in task scores, muscle activity & arm movement.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in emg onset from baseline (before training on day 1) to post (after training on day 3)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in emg onset from baseline (before training on day 1) to post (after training on day 3) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in EMG (electromyography) amplitude (in mV) during the functional reaching task
Change in EMG (electromyography) onset (in ms) during functional reaching task
Change in dressing task scores
+5 more
Secondary outcome measures
Retention in functional reaching task scores
Retention in skill transfer 1 : sorting task scores
Retention in skill transfer 2: dressing task

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: START (Startle Adjuvant Rehabilitation Therapy)Experimental Treatment1 Intervention
Participants in this group practice a functional reaching task with the START condition (startling acoustic stimuli applied during 33% of trials).
Group II: ControlPlacebo Group1 Intervention
Participants in this group will practice a functional reaching task without the START (Startle Adjuvant Rehabilitation Therapy) intervention

Find a Location

Who is running the clinical trial?

Arizona State UniversityLead Sponsor
283 Previous Clinical Trials
109,484 Total Patients Enrolled
4 Trials studying Stroke
148 Patients Enrolled for Stroke

Media Library

START - Startle Adjuvant Rehabilitation Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05881096 — Phase < 1
Stroke Research Study Groups: START (Startle Adjuvant Rehabilitation Therapy), Control
Stroke Clinical Trial 2023: START - Startle Adjuvant Rehabilitation Therapy Highlights & Side Effects. Trial Name: NCT05881096 — Phase < 1
START - Startle Adjuvant Rehabilitation Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05881096 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What qualification criteria must I meet to participate in this clinical research endeavor?

"To be eligible for enrolment, individuals must have suffered a stroke and satisfy the age criteria of 18-99. Approximately 30 participants will take part in this investigation."

Answered by AI

Does this research initiative include participants aged 75 and over?

"Based on the eligibility conditions for this medical trial, potential participants must be a minimum of 18 and no more than 99 years old."

Answered by AI

How many participants have been accepted into this clinical trial?

"Affirmative. According to clinicaltrials.gov, this trial is actively enrolling participants after being published on June 7th 2022 and last updated on May 28th 2023. 30 individuals are needed from one testing centre for the research to be completed successfully."

Answered by AI

Is this research currently recruiting participants?

"Clinicaltrials.gov details that this clinical trial is presently seeking participants, which was first posted on June 7th 2022 and last amended on May 28 2023."

Answered by AI
~11 spots leftby Apr 2025